A project with Tokyo Medical Dental University, which is based on SUSMED’s clinical trial system implementing blockchain technology, has been adopted as Japan Agency for Medical Research and Development (a.k.a AMED) program.
The system is expected to make clinical trials efficient by eliminating SDV process, and this project aims for demonstrating how much time and cost can be saved by using it.